Literature DB >> 12910873

[Anti-HEV seroprevalence in the area of Lecce].

A De Donno1, M Chironna, R Craca, A Paiano, A Zizza, M Guido, F Carrozzini, C Germinario, G Gabutti.   

Abstract

Hepatitis E virus (HEV) is the causative agent of an enterically transmitted viral hepatitis associated with inadequate hygienic conditions. Hepatitis E is endemic in developing countries where it occurs both in sporadic and epidemic form. Outbreaks have been reported in different areas of the world. The aim of the present work was to assess the seroprevalence of HEV infection in the general population and in different risk groups in the area of Lecce. The presence of anti-HEV antibodies was ascertained by qualitative ELISA (Abbott HEV EIA) and Western Blot (Recomblot HEV IgG/IgM, Mikrogen). The prevalence of anti-HEV in the general population was 2.9% while in intravenous drug users, hemodialized patients and immigrants the seroprevalence rates were 0.7%, 4.3% and 15.3% respectively. Our data show a circulation of HEV at low level in the area of Lecce which is endemic for hepatitis A. Higher seroprevalence rates were found in hemodialized patients and remarkably in immigrants coming from endemic areas like Turkey.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12910873

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  6 in total

1.  Seroprevalence of hepatitis E virus among blood donors in a district of southern Italy.

Authors:  Gaetano Scotto; Adele Giammario; Michele Centra; Francesco Vittorio; Domenico Martinelli; Vincenzina Fazio
Journal:  Blood Transfus       Date:  2012-05-31       Impact factor: 3.443

2.  Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China.

Authors:  Wei-Min Ke; Xue-Jun Li; Li-Na Yu; Jing Lai; Xiao-He Li; Zhi-Liang Gao; Pei-Jia Chen
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

3.  Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy).

Authors:  G Scotto; D Martinelli; M Centra; M Querques; F Vittorio; P Delli Carri; A Tartaglia; F Campanale; F Bulla; R Prato; V Fazio
Journal:  Epidemiol Infect       Date:  2013-05-15       Impact factor: 4.434

Review 4.  Epidemiology of Hepatitis E Virus in European Countries.

Authors:  Daniele Lapa; Maria Rosaria Capobianchi; Anna Rosa Garbuglia
Journal:  Int J Mol Sci       Date:  2015-10-27       Impact factor: 5.923

5.  Hepatitis E and blood donation safety in selected European countries: a shift to screening?

Authors:  Dragoslav Domanović; Richard Tedder; Johannes Blümel; Hans Zaaijer; Pierre Gallian; Christoph Niederhauser; Silvia Sauleda Oliveras; Joan O'Riordan; Fiona Boland; Lene Harritshøj; Maria São José Nascimento; Anna Rita Ciccaglione; Constatina Politis; Cornelia Adlhoch; Benoit Flan; Wahiba Oualikene-Gonin; Guy Rautmann; Paul Strengers; Patricia Hewitt
Journal:  Euro Surveill       Date:  2017-04-20

6.  Seroprevalence of Hepatitis E Virus in Roma Settlements: A Comparison with the General Population in Slovakia.

Authors:  Monika Halánová; Eduard Veseliny; Zuzana Kalinová; Peter Jarčuška; Martin Janičko; Ingrid Urbančíková; Daniel Pella; Sylvia Dražilová; Ingrid Babinská
Journal:  Int J Environ Res Public Health       Date:  2018-05-03       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.